MeSH D001932 - brain neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Etoposide | Etoposide |  | 1994-02-10 |  |  |
| Methylprednisolone | Methylprednisolone |  | 2006-10-27 |  |  | |
| Prednisolone | Prednisolone |  | 1999-05-28 |  |  | |
| Prednisolone | Prelone |  | 1986-02-04 |  |  | |
| Etoposide | Toposar |  | 1995-02-27 |  |  | |
| Novast Laboratories | Methylprednisolone | Methylprednisolone |  | 2019-01-09 |  |  |
| Taro Pharmaceutical | Prednisolone | Flo-pred | 2028-10-11 | 2008-01-17 |  |  |
| Ingenus | Carmustine | Carmustine |  | 2022-06-21 |  |  |
| Mylan | Etoposide | Etoposide |  | 2001-09-19 |  |  |
| Carmustine | Carmustine |  | 2023-03-03 |  |  | |
| Sandoz | Methylprednisolone | Methylprednisolone |  | 1997-10-31 |  |  |
| Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1993-05-27 |  |  | |
| Prednisolone | Omnipred |  | 1982-01-01 |  |  | |
| Organon | Methylprednisolone | Methylprednisolone |  | 1982-06-25 |  |  |
| Novartis | Prednisolone | Inflamase |  | 1982-01-01 |  |  |
| Prednisolone, Sulfacetamide | Vasocidin |  | 1984-10-05 |  |  | |
| Bausch Health Companies | Prednisolone | Prednisolone |  | 1994-07-29 |  |  |
| Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1995-12-29 |  |  | |
| Prednisolone, Sulfacetamide | Sulphrin |  | 1982-12-28 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
58%94/163
Phase 2
29%48/163
Phase 3
31%23/75
Approved: 14Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use